Lundanes and Colleagues' Revolutionary Analysis
In this study written by Lundanes et al. (2026) [1], the effect of nutritional strategies on pain in women diagnosed with lipedema and obesity is examined from a perspective that has not been much focused on so far: through plasma fatty acid composition. In the thousands of cases I have seen throughout my professional life, the most common complaint of my patients was often chronic pain, which is indescribable and sometimes feels like a stab, rather than aesthetic concerns. This study fills a gap that we surgeons observe in a clinical setting but have not fully substantiated with biochemical evidence. While the literature typically explains the mechanism of lipedema pain through inflammation or increased tissue pressure, this research demonstrates how the quality of fats circulating in our blood can 'modulate' (adjust) pain directly.
A Fresh Breath Added to the Literature: What's New?
The most distinguishing feature of this article, which separates it from the other thousands of lipedema articles in my library, is its focus not only on weight loss but also on the diversity of fatty acids. The existing literature generally states that low-carbohydrate diets reduce pain [2]. However, the answers given to the question of why have always been vague. Lundanes and his team, by comparing two different diet groups (Low Carbohydrate - LCD and Low Fat - LFD) in this study, reveal that the decrease in pain is actually directly related to the reduction of saturated fatty acids (SFA), particularly Myristic Acid and Palmitic Acid levels. This is truly 'new' information for the lipedema literature. No previous clinical study had clearly demonstrated with such precise figures that a one-unit decrease in plasma myristic acid levels could correlate to a one-point improvement on the pain scale.
The Hidden Culprit of Pain: Myristic Acid and the Bad Fuel Analogy
There is a comparison I frequently use when explaining the situation to my patients: Think of your body like a car engine. If you put low-quality, sludge-producing fuel into this engine, it stutters and overheats. Myristic Acid is that 'sludge-producing' bad fuel for lipedematous tissue. According to the results of the study, in the low-carbohydrate group, the level of this acid dramatically decreased and, in parallel, patients' pain significantly reduced. My clinical experiences confirm that when we cut carbohydrates, the body does not only burn fat but also begins to clean these specific types of fats that trigger pain from the bloodstream. The secret of why the low carbohydrate diet is far more successful in pain control than the low-fat diet may lie here.
Inflammation or Fibrosis? Paradigm-Shifting Results
The prevailing view in the world of lipedema for a long time has been that pain occurs as a result of systemic inflammation. However, this study provides a clue that contradicts some previous data. The researchers state that the decrease in pain is not directly related to changes in systemic inflammation markers (such as cytokines), but rather to changes in the fatty acid profile. This situation supports the theory proposed by Bertsch et al. (2020) that pain is more related to fibrosis (hardening of connective tissue) and pressure in the extracellular matrix [3]. As the fatty acid composition changes, the idea that the hardening in the tissue (fibrosis) may decrease or the pressure on nerve endings may lighten demonstrates once again how vital nutrition is for us surgeons in the preoperative and postoperative period.
Low Carbohydrate (LCD) vs. Low Fat (LFD): Who is the Real Winner?
In the study, both diet groups consumed a total of 1200 calories and both groups lost weight. However, the difference is striking: the pain score for women on the low carbohydrate diet fell by -1.3 units, while only a -0.2 unit change occurred in those on the low-fat diet. This is the greatest evidence that the 'calorie is a calorie' approach does not work in lipedema. When the fatty acids were analyzed, serious decreases in monounsaturated fats such as Palmitoleic Acid and Oleic Acid were observed in the LCD group. More importantly, the reduction in saturated fats like myristic acid and palmitic acid resulted only in the LCD group in statistically significant pain improvement. Compared to other studies in the literature, this finding is fully aligned with studies conducted by Sekar et al. (2020) in animals, which showed that saturated fats trigger pain [4].
My Clinical Observations and Practical Implications
In my clinic, I recommend patients for whom I plan lipedema surgery to switch to a low-carbohydrate diet at least 8 weeks before the operation. Generally, the feedback I receive is like, 'Doctor, that heavy load and soreness in my legs went away without surgery.' The study by Lundanes and his team scientifically explains why I receive this feedback: The levels of myristic acid in my patients' plasma are decreasing! This acid is found not only in animal fats but also in some plant sources, but the real problem is how the body processes these acids when combined with high carbohydrates. The increase in Lignoceric Acid levels in the low-fat diet seen in the study indicates that the body is trying to synthesize fatty acids (de novo lipogenesis) to compensate for the lack of fat, which is not a desirable situation for lipedematous tissue.
Does the Nutritional Prescription Change for a Pain-Free Life?
This article serves as a beacon showing how 'what you eat' makes a difference at the plasma level, not just 'how much you eat' in lipedema management. Studies conducted by Dinnendahl et al. (2024) highlighted that the pain threshold in patients with lipedema changes with tissue pressure [5]. Lundanes' findings whisper that the chemical trigger behind this tissue pressure could be the profile of saturated fatty acids. Particularly, controlling the intake of Myristic Acid and Palmitic Acid and the possibility of achieving this only with a low-carbohydrate strategy is the most practical implication for our patients.
Conclusion: A Step as Important as Surgery
In conclusion, this study tells us: Lipedema pain is not fate and cannot be merely masked with a pain reliever. Changing your plasma fatty acid composition is the key to extinguishing that chronic inflammation in your legs. As a surgeon, I can say that the tissue quality of a patient who has corrected their plasma fat profile through nutrition is far superior during and after the healing period of surgery. This article is invaluable for shifting the focus from the literature's obsession with 'inflammation' to 'fatty acid quality.' In the future, we may talk about managing lipedema pain not only through diet but also with supplements that directly target myristic acid.